Sarah Ford | February 9, 2015
Research progress report: Frizzled 9 and lung cancer chemoprevention
Every year, lung cancer leads to more deaths than any other cancer. An estimated 159,2601Â Americans were expected to die from lung cancer in 2014, accounting for about 27% of all cancer deaths.
The Foundation is committed to lung cancer prevention research and currently supports five researchers studying different aspects of preventing this deadly disease. One of these researchers is Meredith Tennis, Ph.D., of the University of Colorado Denver. Her project focuses on Frizzled 9, a protein that helps to maintain normal lung tissue, as a potential biomarker2Â to predict how patients may respond to the drug iloprost, a drug being used for chemoprevention.
Get Resources and Insights Straight To Your Inbox
Explore More Articles
$1 Billion in Giving: America’s Charities Reaches a Historic Milestone
A testament to the impact of mobilizing the power of giving. We have some extraordinary news to share. In 2025, America’s Charities crossed a threshold that few organizations…
America’s Charities Named ‘Best Nonprofit To Work For’ For Fifth Consecutive Year
Washington, D.C. – April 1, 2025 – America’s Charities, the nonprofit that mobilizes the power of giving as a leading provider of volunteering, workplace giving,…
January is National Poverty in America Awareness Month
Hunger and malnutrition, limited access to education and other basic services, social discrimination and exclusion, disabilities, restricted access to participation in the democratic process. These…
Get Resources and Insights Straight To Your Inbox
Receive our monthly/bi-monthly newsletter filled with information about causes, nonprofit impact, and topics important for corporate social responsibility and employee engagement professionals, including disaster response, workplace giving, matching gifts, employee assistance funds, volunteering, scholarship award program management, grantmaking, and other philanthropic initiatives.
